Belgian Cancer Registry on FHIR
0.1.0 - ci-build
Belgian Cancer Registry on FHIR
0.1.0 - ci-build
Belgian Cancer Registry on FHIR - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2026-05-04 |
Definitions for the bcr-breast-tumour-supplement logical model.
Guidance on how to interpret the contents of this table can be foundhere
| 0. bcr-breast-tumour-supplement | |
| Definition | Logical model of the breast-tumour-specific supplement to the standard cancer registration form (Bijlage 55, vervolg 1). Contains menopausal status, molecular markers (with separate values for tumour 1 and, when multifocal, tumour 2), and surgical / lymph node data. Source: Bijlage 55 (vervolg 1) of the RIZIV Verordening of 28 July 2003, amended 15 December 2025. |
| Short | BCR Breast Tumour Supplement — Bijlage 55 vervolg 1 (Logical Model) |
| Control | 0..* |
| Is Modifier | false |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. bcr-breast-tumour-supplement.menopausalStatus | |
| Definition | Menopausal status. Codes: ja / nee / onduidelijk / niet gekend / niet van toepassing (mannelijke patiënt). |
| Short | Menopausal status at diagnosis |
| Control | 0..1 |
| Binding | The codes SHALL be taken from BCR Menopausal Status (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-menopausal-status-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 4. bcr-breast-tumour-supplement.molecularMarker | |
| Definition | One molecular-marker measurement on tumour 1, or on tumour 2 in the case of multifocal disease. |
| Short | Molecular marker result |
| Control | 0..* |
| Type | BackboneElement |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) |
| 6. bcr-breast-tumour-supplement.molecularMarker.id | |
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
| Short | Unique id for inter-element referencing |
| Control | 0..1 |
| Type | string |
| Is Modifier | false |
| XML Format | In the XML format, this property is represented as an attribute. |
| Summary | false |
| 8. bcr-breast-tumour-supplement.molecularMarker.extension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
| Short | Additional content defined by implementations |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | false |
| Summary | false |
| Alternate Names | extensions, user content |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) |
| Slicing | This element introduces a set of slices on bcr-breast-tumour-supplement.molecularMarker.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: |
| 10. bcr-breast-tumour-supplement.molecularMarker.modifierExtension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
| Short | Extensions that cannot be ignored even if unrecognized |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them |
| Summary | true |
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
| Alternate Names | extensions, user content, modifiers |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) |
| 12. bcr-breast-tumour-supplement.molecularMarker.marker | |
| Definition | Molecular marker. Form-listed markers: ER (oestrogen receptor), PR (progesterone receptor), HER2-IHC (HER2 IHC score), HER2-IHC-ISH (combined HER2 status), BRCA1-2, CHEK2, PALB2, ATM, PIK3CA (PIKCA3 on the form), KI67 (Ki-67 before systemic therapy), OTHER (free-text marker name). |
| Short | Marker |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Molecular Marker (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 14. bcr-breast-tumour-supplement.molecularMarker.otherMarkerName | |
| Definition | Free-text marker name when |
| Short | Other marker name |
| Control | 0..1 |
| Type | string |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 16. bcr-breast-tumour-supplement.molecularMarker.tumourIndex | |
| Definition | Tumour to which the result applies: 1 (primary tumour) or 2 (second tumour, only in multifocal disease). |
| Short | Tumour index |
| Control | 1..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 18. bcr-breast-tumour-supplement.molecularMarker.testDate | |
| Definition | Date the marker was measured. |
| Short | Test date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 20. bcr-breast-tumour-supplement.molecularMarker.result | |
| Definition | Result of the marker. Permitted codings depend on the marker:
|
| Short | Result |
| Control | 0..1 |
| Binding | Unless not suitable, these codes SHALL be taken from BCR Molecular Marker Result (union) (extensible to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-result-vs) |
| Type | CodeableConcept |
| 22. bcr-breast-tumour-supplement.molecularMarker.resultPercentage | |
| Definition | Numeric percentage result. Used for Ki-67 ( |
| Short | Result percentage |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 24. bcr-breast-tumour-supplement.surgeryPerformed | |
| Definition | Indicates whether section 3 (surgical data) is in scope. When false or absent, the surgery fields below are not applicable. |
| Short | Surgery performed |
| Control | 0..1 |
| Type | boolean |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 26. bcr-breast-tumour-supplement.maxPathDiameterInvasiveMm | |
| Definition | Maximale pathologische doormeter invasieve component vóór systemische therapie. |
| Short | Max pathological diameter, invasive component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 28. bcr-breast-tumour-supplement.maxPathDiameterInSituMm | |
| Definition | Maximale pathologische doormeter in situ component vóór systemische therapie. |
| Short | Max pathological diameter, in situ component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 30. bcr-breast-tumour-supplement.minMarginDistanceInvasiveMm | |
| Definition | Minimale afstand van de invasieve component tot de snijrand. |
| Short | Min distance, invasive component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 32. bcr-breast-tumour-supplement.minMarginDistanceInSituMm | |
| Definition | Minimale afstand van de in situ component tot snijrand. |
| Short | Min distance, in situ component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 34. bcr-breast-tumour-supplement.lymphNodeAssessment | |
| Definition | One row of the sentinel / axillary / other-nodes table. |
| Short | Lymph node assessment |
| Control | 0..* |
| Type | BackboneElement |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) |
| 36. bcr-breast-tumour-supplement.lymphNodeAssessment.id | |
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
| Short | Unique id for inter-element referencing |
| Control | 0..1 |
| Type | string |
| Is Modifier | false |
| XML Format | In the XML format, this property is represented as an attribute. |
| Summary | false |
| 38. bcr-breast-tumour-supplement.lymphNodeAssessment.extension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
| Short | Additional content defined by implementations |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | false |
| Summary | false |
| Alternate Names | extensions, user content |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) |
| Slicing | This element introduces a set of slices on bcr-breast-tumour-supplement.lymphNodeAssessment.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: |
| 40. bcr-breast-tumour-supplement.lymphNodeAssessment.modifierExtension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
| Short | Extensions that cannot be ignored even if unrecognized |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them |
| Summary | true |
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
| Alternate Names | extensions, user content, modifiers |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) |
| 42. bcr-breast-tumour-supplement.lymphNodeAssessment.location | |
| Definition | Lymph node group. Codes: SENTINEL (Sentinelklieren), AXILLARY (Axillaire klieren), OTHER (Andere klieren). |
| Short | Node location |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Lymph Node Location (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-lymph-node-location-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 44. bcr-breast-tumour-supplement.lymphNodeAssessment.examined | |
| Definition | Aantal onderzocht. |
| Short | Number examined |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 46. bcr-breast-tumour-supplement.lymphNodeAssessment.positive | |
| Definition | Aantal positief. |
| Short | Number positive |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 48. bcr-breast-tumour-supplement.lymphNodeAssessment.assessmentDate | |
| Definition | Date of the lymph node assessment. |
| Short | Assessment date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
Guidance on how to interpret the contents of this table can be foundhere
| 0. bcr-breast-tumour-supplement | |
| Definition | Logical model of the breast-tumour-specific supplement to the standard cancer registration form (Bijlage 55, vervolg 1). Contains menopausal status, molecular markers (with separate values for tumour 1 and, when multifocal, tumour 2), and surgical / lymph node data. Source: Bijlage 55 (vervolg 1) of the RIZIV Verordening of 28 July 2003, amended 15 December 2025. |
| Short | BCR Breast Tumour Supplement — Bijlage 55 vervolg 1 (Logical Model) |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. bcr-breast-tumour-supplement.menopausalStatus | |
| Definition | Menopausal status. Codes: ja / nee / onduidelijk / niet gekend / niet van toepassing (mannelijke patiënt). |
| Short | Menopausal status at diagnosis |
| Control | 0..1 |
| Binding | The codes SHALL be taken from BCR Menopausal Status (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-menopausal-status-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 4. bcr-breast-tumour-supplement.molecularMarker | |
| Definition | One molecular-marker measurement on tumour 1, or on tumour 2 in the case of multifocal disease. |
| Short | Molecular marker result |
| Control | 0..* |
| Type | BackboneElement |
| 6. bcr-breast-tumour-supplement.molecularMarker.marker | |
| Definition | Molecular marker. Form-listed markers: ER (oestrogen receptor), PR (progesterone receptor), HER2-IHC (HER2 IHC score), HER2-IHC-ISH (combined HER2 status), BRCA1-2, CHEK2, PALB2, ATM, PIK3CA (PIKCA3 on the form), KI67 (Ki-67 before systemic therapy), OTHER (free-text marker name). |
| Short | Marker |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Molecular Marker (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 8. bcr-breast-tumour-supplement.molecularMarker.otherMarkerName | |
| Definition | Free-text marker name when |
| Short | Other marker name |
| Control | 0..1 |
| Type | string |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 10. bcr-breast-tumour-supplement.molecularMarker.tumourIndex | |
| Definition | Tumour to which the result applies: 1 (primary tumour) or 2 (second tumour, only in multifocal disease). |
| Short | Tumour index |
| Control | 1..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 12. bcr-breast-tumour-supplement.molecularMarker.testDate | |
| Definition | Date the marker was measured. |
| Short | Test date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 14. bcr-breast-tumour-supplement.molecularMarker.result | |
| Definition | Result of the marker. Permitted codings depend on the marker:
|
| Short | Result |
| Control | 0..1 |
| Binding | Unless not suitable, these codes SHALL be taken from BCR Molecular Marker Result (union) (extensible to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-result-vs) |
| Type | CodeableConcept |
| 16. bcr-breast-tumour-supplement.molecularMarker.resultPercentage | |
| Definition | Numeric percentage result. Used for Ki-67 ( |
| Short | Result percentage |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 18. bcr-breast-tumour-supplement.surgeryPerformed | |
| Definition | Indicates whether section 3 (surgical data) is in scope. When false or absent, the surgery fields below are not applicable. |
| Short | Surgery performed |
| Control | 0..1 |
| Type | boolean |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 20. bcr-breast-tumour-supplement.maxPathDiameterInvasiveMm | |
| Definition | Maximale pathologische doormeter invasieve component vóór systemische therapie. |
| Short | Max pathological diameter, invasive component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 22. bcr-breast-tumour-supplement.maxPathDiameterInSituMm | |
| Definition | Maximale pathologische doormeter in situ component vóór systemische therapie. |
| Short | Max pathological diameter, in situ component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 24. bcr-breast-tumour-supplement.minMarginDistanceInvasiveMm | |
| Definition | Minimale afstand van de invasieve component tot de snijrand. |
| Short | Min distance, invasive component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 26. bcr-breast-tumour-supplement.minMarginDistanceInSituMm | |
| Definition | Minimale afstand van de in situ component tot snijrand. |
| Short | Min distance, in situ component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 28. bcr-breast-tumour-supplement.lymphNodeAssessment | |
| Definition | One row of the sentinel / axillary / other-nodes table. |
| Short | Lymph node assessment |
| Control | 0..* |
| Type | BackboneElement |
| 30. bcr-breast-tumour-supplement.lymphNodeAssessment.location | |
| Definition | Lymph node group. Codes: SENTINEL (Sentinelklieren), AXILLARY (Axillaire klieren), OTHER (Andere klieren). |
| Short | Node location |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Lymph Node Location (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-lymph-node-location-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 32. bcr-breast-tumour-supplement.lymphNodeAssessment.examined | |
| Definition | Aantal onderzocht. |
| Short | Number examined |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 34. bcr-breast-tumour-supplement.lymphNodeAssessment.positive | |
| Definition | Aantal positief. |
| Short | Number positive |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 36. bcr-breast-tumour-supplement.lymphNodeAssessment.assessmentDate | |
| Definition | Date of the lymph node assessment. |
| Short | Assessment date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
Guidance on how to interpret the contents of this table can be foundhere
| 0. bcr-breast-tumour-supplement | |
| Definition | Logical model of the breast-tumour-specific supplement to the standard cancer registration form (Bijlage 55, vervolg 1). Contains menopausal status, molecular markers (with separate values for tumour 1 and, when multifocal, tumour 2), and surgical / lymph node data. Source: Bijlage 55 (vervolg 1) of the RIZIV Verordening of 28 July 2003, amended 15 December 2025. |
| Short | BCR Breast Tumour Supplement — Bijlage 55 vervolg 1 (Logical Model) |
| Control | 0..* |
| Is Modifier | false |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. bcr-breast-tumour-supplement.menopausalStatus | |
| Definition | Menopausal status. Codes: ja / nee / onduidelijk / niet gekend / niet van toepassing (mannelijke patiënt). |
| Short | Menopausal status at diagnosis |
| Control | 0..1 |
| Binding | The codes SHALL be taken from BCR Menopausal Status (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-menopausal-status-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 4. bcr-breast-tumour-supplement.molecularMarker | |
| Definition | One molecular-marker measurement on tumour 1, or on tumour 2 in the case of multifocal disease. |
| Short | Molecular marker result |
| Control | 0..* |
| Type | BackboneElement |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) |
| 6. bcr-breast-tumour-supplement.molecularMarker.id | |
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
| Short | Unique id for inter-element referencing |
| Control | 0..1 |
| Type | string |
| Is Modifier | false |
| XML Format | In the XML format, this property is represented as an attribute. |
| Summary | false |
| 8. bcr-breast-tumour-supplement.molecularMarker.extension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
| Short | Additional content defined by implementations |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | false |
| Summary | false |
| Alternate Names | extensions, user content |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) |
| Slicing | This element introduces a set of slices on bcr-breast-tumour-supplement.molecularMarker.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: |
| 10. bcr-breast-tumour-supplement.molecularMarker.modifierExtension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
| Short | Extensions that cannot be ignored even if unrecognized |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them |
| Summary | true |
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
| Alternate Names | extensions, user content, modifiers |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) |
| 12. bcr-breast-tumour-supplement.molecularMarker.marker | |
| Definition | Molecular marker. Form-listed markers: ER (oestrogen receptor), PR (progesterone receptor), HER2-IHC (HER2 IHC score), HER2-IHC-ISH (combined HER2 status), BRCA1-2, CHEK2, PALB2, ATM, PIK3CA (PIKCA3 on the form), KI67 (Ki-67 before systemic therapy), OTHER (free-text marker name). |
| Short | Marker |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Molecular Marker (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 14. bcr-breast-tumour-supplement.molecularMarker.otherMarkerName | |
| Definition | Free-text marker name when |
| Short | Other marker name |
| Control | 0..1 |
| Type | string |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 16. bcr-breast-tumour-supplement.molecularMarker.tumourIndex | |
| Definition | Tumour to which the result applies: 1 (primary tumour) or 2 (second tumour, only in multifocal disease). |
| Short | Tumour index |
| Control | 1..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 18. bcr-breast-tumour-supplement.molecularMarker.testDate | |
| Definition | Date the marker was measured. |
| Short | Test date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 20. bcr-breast-tumour-supplement.molecularMarker.result | |
| Definition | Result of the marker. Permitted codings depend on the marker:
|
| Short | Result |
| Control | 0..1 |
| Binding | Unless not suitable, these codes SHALL be taken from BCR Molecular Marker Result (union) (extensible to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-molecular-marker-result-vs) |
| Type | CodeableConcept |
| 22. bcr-breast-tumour-supplement.molecularMarker.resultPercentage | |
| Definition | Numeric percentage result. Used for Ki-67 ( |
| Short | Result percentage |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 24. bcr-breast-tumour-supplement.surgeryPerformed | |
| Definition | Indicates whether section 3 (surgical data) is in scope. When false or absent, the surgery fields below are not applicable. |
| Short | Surgery performed |
| Control | 0..1 |
| Type | boolean |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 26. bcr-breast-tumour-supplement.maxPathDiameterInvasiveMm | |
| Definition | Maximale pathologische doormeter invasieve component vóór systemische therapie. |
| Short | Max pathological diameter, invasive component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 28. bcr-breast-tumour-supplement.maxPathDiameterInSituMm | |
| Definition | Maximale pathologische doormeter in situ component vóór systemische therapie. |
| Short | Max pathological diameter, in situ component, before systemic therapy (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 30. bcr-breast-tumour-supplement.minMarginDistanceInvasiveMm | |
| Definition | Minimale afstand van de invasieve component tot de snijrand. |
| Short | Min distance, invasive component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 32. bcr-breast-tumour-supplement.minMarginDistanceInSituMm | |
| Definition | Minimale afstand van de in situ component tot snijrand. |
| Short | Min distance, in situ component to surgical margin (mm) |
| Control | 0..1 |
| Type | decimal |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 34. bcr-breast-tumour-supplement.lymphNodeAssessment | |
| Definition | One row of the sentinel / axillary / other-nodes table. |
| Short | Lymph node assessment |
| Control | 0..* |
| Type | BackboneElement |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) |
| 36. bcr-breast-tumour-supplement.lymphNodeAssessment.id | |
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
| Short | Unique id for inter-element referencing |
| Control | 0..1 |
| Type | string |
| Is Modifier | false |
| XML Format | In the XML format, this property is represented as an attribute. |
| Summary | false |
| 38. bcr-breast-tumour-supplement.lymphNodeAssessment.extension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
| Short | Additional content defined by implementations |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | false |
| Summary | false |
| Alternate Names | extensions, user content |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) |
| Slicing | This element introduces a set of slices on bcr-breast-tumour-supplement.lymphNodeAssessment.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: |
| 40. bcr-breast-tumour-supplement.lymphNodeAssessment.modifierExtension | |
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
| Short | Extensions that cannot be ignored even if unrecognized |
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
| Control | 0..* |
| Type | Extension |
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them |
| Summary | true |
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
| Alternate Names | extensions, user content, modifiers |
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) |
| 42. bcr-breast-tumour-supplement.lymphNodeAssessment.location | |
| Definition | Lymph node group. Codes: SENTINEL (Sentinelklieren), AXILLARY (Axillaire klieren), OTHER (Andere klieren). |
| Short | Node location |
| Control | 1..1 |
| Binding | The codes SHALL be taken from BCR Lymph Node Location (required to https://www.ehealth.fgov.be/standards/fhir/registries/bcr/ValueSet/bcr-lymph-node-location-vs) |
| Type | code |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 44. bcr-breast-tumour-supplement.lymphNodeAssessment.examined | |
| Definition | Aantal onderzocht. |
| Short | Number examined |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 46. bcr-breast-tumour-supplement.lymphNodeAssessment.positive | |
| Definition | Aantal positief. |
| Short | Number positive |
| Control | 0..1 |
| Type | unsignedInt |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
| 48. bcr-breast-tumour-supplement.lymphNodeAssessment.assessmentDate | |
| Definition | Date of the lymph node assessment. |
| Short | Assessment date |
| Control | 0..1 |
| Type | date |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |